PMID: 11927287Apr 3, 2002Paper

Epigenomics and epigenetic therapy of cancer

Trends in Molecular Medicine
Robert Brown, Gordon Strathdee

Abstract

Epigenetic inactivation of genes that are crucial for the control of normal cell growth is a hallmark of cancer cells. These epigenetic mechanisms include crosstalk between DNA methylation, histone modification and other components of chromatin higher-order structure, and lead to the regulation of gene transcription. Re-expression of genes epigenetically inactivated can result in the suppression of tumour growth or sensitization to other anticancer therapies. Small molecules that reverse epigenetic inactivation are now undergoing clinical trials in cancer patients. This, together with epigenomic analysis of chromatin alterations such as DNA methylation and histone acetylation, opens up the potential both to define epigenetic patterns of gene inactivation in tumours and to use drugs that target epigenetic silencing.

References

Apr 21, 1995·Cell·P W LairdR Jaenisch
Apr 1, 1993·Current Opinion in Genetics & Development·P H Tate, A P Bird
Jan 1, 1997·Annual Review of Genetics·M S Bartolomei, S M Tilghman
Jan 1, 1997·Annual Review of Genetics·E HeardP Avner
Dec 10, 1999·Cell·A P Bird, A P Wolffe
Aug 3, 2000·Journal of the National Cancer Institute·P A MarksR A Rifkind
May 23, 2001·Journal of Medical Genetics·J F Costello, C Plass
Aug 29, 2001·The Journal of Biological Chemistry·N Cervoni, M Szyf
Sep 20, 2001·Current Medicinal Chemistry·M Jung
Oct 24, 2001·Current Opinion in Oncology·P A MarksR A Rifkind
Dec 19, 2001·The Journal of Pathology·Manel Esteller, James G Herman
Feb 28, 2004·Expert Reviews in Molecular Medicine·G Strathdee, R Brown

❮ Previous
Next ❯

Citations

Feb 22, 2008·Acta Biotheoretica·M BizzarriF D'Anselmi
Jun 10, 2006·Journal of Inherited Metabolic Disease·Claudine Junien
Apr 20, 2004·Toxicology and Applied Pharmacology·Jonathan G MoggsRuth A Roberts
Feb 5, 2003·Cancer Letters·Kenneth P Nephew, Tim Hui-Ming Huang
Jan 8, 2004·Seminars in Cancer Biology·Nathalie Rouas-FreissEdgardo D Carosella
Dec 11, 2002·The Lancet Oncology·Mukesh Verma, Sudhir Srivastava
May 17, 2002·Nature·Allan Balmain
Sep 2, 2005·Nature Reviews. Genetics·Keith D Robertson
Mar 21, 2001·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·E HovigE B Smeland
Jan 5, 2007·Nucleic Acids Research·Arie B BrinkmanHendrik G Stunnenberg
Sep 24, 2005·Development, Growth & Differentiation·Natalija Pozdniakovaite, Violeta Popendikyte
Mar 26, 2009·Annual Review of Biochemistry·Oliver J Rando, Howard Y Chang
Jun 3, 2004·The Journal of Clinical Investigation·Irma AiroldiVito Pistoia
Aug 13, 2010·Biomarkers in Medicine·Rudolf NapieralskiManfred Schmitt
May 11, 2013·Genetics and Molecular Research : GMR·Z HussainF N Almajhdi
Nov 24, 2011·Biochemistry Research International·Cheng Ji
Sep 28, 2013·Pediatric Surgery International·Ki Cheong Park, Seung Hoon Choi
Feb 14, 2013·Bioorganic & Medicinal Chemistry Letters·Patricia García-DomínguezAngel R de Lera
Jun 11, 2015·Protein Science : a Publication of the Protein Society·Rajal Sharma, Ming-Ming Zhou
May 28, 2008·Biochimica Et Biophysica Acta·Alberto MilliPier Giorgio Righetti
Jan 29, 2008·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Katan PatelDuncan I Jodrell
Jun 5, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D MastrangeloT Hadjistilianou
Feb 22, 2005·Journal of Cellular Biochemistry·Paula S EspinoJames R Davie
May 2, 2003·Annals of the New York Academy of Sciences·Thea Kalebic
Oct 24, 2007·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·C Junien, P Nathanielsz
Jan 22, 2005·Experimental Hematology·Sakura SakajiriH Phillip Koeffler
Sep 27, 2015·Biochimica Et Biophysica Acta·Julhash U KaziLars Rönnstrand
Jul 11, 2006·Critical Reviews in Oncology/hematology·Silvana CanevariMarco A Pierotti
Mar 11, 2006·Cancer Genetics and Cytogenetics·Fabrício F CostaAnamaria A Camargo
May 17, 2007·American Journal of Medical Genetics. Part a·Kyoko TakanoShinji Saitoh
Mar 16, 2006·Cancer Investigation·Piyush Tripathi, Suraksha Agrawal
Aug 24, 2011·Dermatology Research and Practice·Adriana Taveira da Cruz, Miriam Galvonas Jasiulionis
Sep 12, 2002·Expert Opinion on Therapeutic Targets·Andrew M SchumacherD Martin Watterson
Dec 4, 2003·Expert Opinion on Therapeutic Targets·Thea Kalebic
Nov 18, 2004·American Journal of Obstetrics and Gynecology·Curtis BalchKenneth P Nephew
Mar 30, 2013·Biochemical and Biophysical Research Communications·Seiko FujiiTatsuji Nishihara
Mar 12, 2015·Cancer Biotherapy & Radiopharmaceuticals·Qi-feng CaoHai-bo Shen
Jun 29, 2005·Diabetes·Catherine Gallou-Kabani, Claudine Junien

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.